Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja J Rueten-Budde

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Statistics in Medicine|October 20, 2018
Investigating hospital heterogeneity with a competing risks frailty modelAnja J Rueten-Budde, Hein Putter, Marta Fiocco
Statistical Methods in Medical Research|January 29, 2026
Discrimination performance in illness-death models with interval-censored disease dataMarta Spreafico, Anja J Rueten-Budde, Hein Putter, et al.
BMJ Open|October 13, 2020
Dynamic prediction of overall survival: a retrospective analysis on 979 patients with Ewing sarcoma from the German registryChuchu Liu, Anja J Rueten-Budde, Andreas Ranft, et al.
Journal of Surgical Oncology|December 17, 2020
External validation and adaptation of a dynamic prediction model for patients with high-grade extremity soft tissue sarcomaAnja J Rueten-Budde, Veroniek M van Praag, Michiel A J van de Sande, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2020
Age-related differences of oncological outcomes in primary extremity soft tissue sarcoma: a multistate model including 6260 patientsIbtissam Acem, Cornelis Verhoef, Anja J Rueten-Budde, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2022
Corrigendum to 'Age-related differences of oncological outcomes in primary extremity soft tissue sarcoma: a multistate model including 6260 patients' [Eur J Cancer 141 (2020) 128-136]Ibtissam Acem, Cornelis Verhoef, Anja J Rueten-Budde, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2022
The role of perioperative chemotherapy in primary high-grade extremity soft tissue sarcoma: a risk-stratified analysis using PERSARCIbtissam Acem, Winan J van Houdt, Dirk J Grünhagen, et al.
Cancers|January 30, 2021
Survival Analysis of 3 Different Age Groups and Prognostic Factors among 402 Patients with Skeletal High-Grade Osteosarcoma. Real World Data from a Single Tertiary Sarcoma CenterRichard E Evenhuis, Ibtissam Acem, Anja J Rueten-Budde, et al.
BMJ Open|February 16, 2017
Individualised risk assessment for local recurrence and distant metastases in a retrospective transatlantic cohort of 687 patients with high-grade soft tissue sarcomas of the extremities: a multistate modelJulie J Willeumier, Anja J Rueten-Budde, Lee M Jeys, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2017
A prediction model for treatment decisions in high-grade extremity soft-tissue sarcomas: Personalised sarcoma care (PERSARC)Veroniek M van Praag, Anja J Rueten-Budde, Lee M Jeys, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|October 20, 2018
Investigating hospital heterogeneity with a competing risks frailty modelAnja J Rueten-Budde, Hein Putter, Marta Fiocco
Statistical Methods in Medical Research|January 29, 2026
Discrimination performance in illness-death models with interval-censored disease dataMarta Spreafico, Anja J Rueten-Budde, Hein Putter, et al.
BMJ Open|October 13, 2020
Dynamic prediction of overall survival: a retrospective analysis on 979 patients with Ewing sarcoma from the German registryChuchu Liu, Anja J Rueten-Budde, Andreas Ranft, et al.
Journal of Surgical Oncology|December 17, 2020
External validation and adaptation of a dynamic prediction model for patients with high-grade extremity soft tissue sarcomaAnja J Rueten-Budde, Veroniek M van Praag, Michiel A J van de Sande, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2020
Age-related differences of oncological outcomes in primary extremity soft tissue sarcoma: a multistate model including 6260 patientsIbtissam Acem, Cornelis Verhoef, Anja J Rueten-Budde, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2022
Corrigendum to 'Age-related differences of oncological outcomes in primary extremity soft tissue sarcoma: a multistate model including 6260 patients' [Eur J Cancer 141 (2020) 128-136]Ibtissam Acem, Cornelis Verhoef, Anja J Rueten-Budde, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2022
The role of perioperative chemotherapy in primary high-grade extremity soft tissue sarcoma: a risk-stratified analysis using PERSARCIbtissam Acem, Winan J van Houdt, Dirk J Grünhagen, et al.
Cancers|January 30, 2021
Survival Analysis of 3 Different Age Groups and Prognostic Factors among 402 Patients with Skeletal High-Grade Osteosarcoma. Real World Data from a Single Tertiary Sarcoma CenterRichard E Evenhuis, Ibtissam Acem, Anja J Rueten-Budde, et al.
BMJ Open|February 16, 2017
Individualised risk assessment for local recurrence and distant metastases in a retrospective transatlantic cohort of 687 patients with high-grade soft tissue sarcomas of the extremities: a multistate modelJulie J Willeumier, Anja J Rueten-Budde, Lee M Jeys, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2017
A prediction model for treatment decisions in high-grade extremity soft-tissue sarcomas: Personalised sarcoma care (PERSARC)Veroniek M van Praag, Anja J Rueten-Budde, Lee M Jeys, et al.
Pageof 2